ArticlesHypoxia During Air Travel in Adults With Pulmonary Disease
Section snippets
The Physiological Stresses of Air Travel
As an aircraft ascends to progressively higher altitudes, the air density of the atmosphere decreases exponentially. This, in turn, results in an exponential decrease in both barometric pressure and the partial pressure of atmospheric oxygen (PiO2).28 Most commercial aircraft fly at cruising altitudes between 25,000 and 45,000 feet. To maintain PiO2 and the partial pressure of arterial oxygen (PaO2) at safe levels during flight, commercial aircraft cabins are pressurized.29., 30.
There are
The Preflight Medical Evaluation
The utility of a careful preflight medical evaluation for individuals with cardiopulmonary disorders has been demonstrated in several studies.43., 48., 49. The Aerospace Medical Association and the British Thoracic Society have published comprehensive guidelines for the evaluation and management of individuals before air travel.1., 2. Although there are some differences in these guidelines, they both address the importance of a preflight medical evaluation, the estimation of in-flight PaO2,
The Baseline Medical Evaluation
All individuals with pulmonary disease should have a thorough history and physical examination, as well as the following studies, before air travel: spirometry, arterial blood gasses, SpO2, electrocardiogram for the detection of ischemic changes and dysrhythmias and the measurement of hemoglobin concentration. Patients with chronic obstructive lung disease (COPD) should have maximum voluntary ventilation (MVV) measured in conjunction with spirometry, if not routinely performed. Individuals with
Fifty-Yard and 6-Minute Walk Tests
A 50-yard walk test or 6-minute walk test can be very helpful in the evaluation of some patients with pulmonary disease.1., 2. Although neither has been validated in controlled studies for the preflight evaluation of patients with pulmonary disease, it is generally believed that the ability to increase minute ventilation and cardiac output in response to exercise is a simple, reliable and practical way of assessing the cardiopulmonary reserve that such patients will need to meet the
Evaluation of Preflight PaO2 and SpO2
It is currently recommended that individuals maintain an in-flight PaO2 of 50 mm Hg or greater during air travel.1., 2., 54. The single best predictor of the in-flight PaO2 is the baseline PaO2 at ground altitude.1 A stable, preflight ground PaO2 of 70 mm Hg or greater is generally considered adequate to achieve a PaO2 of 50 mm Hg or greater at an altitude of 8,000 feet, which is the maximum permissible cabin altitude for commercial aircraft.1., 2., 54., 55. It is recommended that individuals who
HAST
Breathing a hypoxic gas mixture of 15.1% oxygen at sea level will simulate breathing air with a PiO2 of 108 mm Hg at the maximum allowable aircraft cabin altitude of 8,000 feet. This is the basis for the hypoxia altitude simulation test (HAST), which was first described by Gong et al12 in 1984.
The HAST is conducted by breathing a hypoxic gas mixture of 15.1% oxygen, balanced with nitrogen, through a tight-fitting face mask or mouthpiece for 20 minutes. Arterial blood gasses are obtained before
Anemia
All patients with pulmonary disease should have the blood hemoglobin concentration measured as part of the preflight medical evaluation. Any such patient with a blood hemoglobin concentration below 8.5 g/dL should be considered for in-flight supplemental oxygen, even if no other indications are present. At such low concentrations of hemoglobin the oxygen-carrying capacity of blood is significantly diminished. Patients with pulmonary disease who have a blood hemoglobin concentration of less than
COPD
Individuals with COPD are especially susceptible to respiratory decompensation and severe hypoxemia during commercial air travel.10., 11., 14., 16., 44., 46., 47., 54., 56. Their ability to increase minute ventilation in response to hypoxia is limited, even with appropriate therapy. This, coupled with underlying ventilation-perfusion mismatching, makes it difficult for some individuals with COPD to maintain adequate oxygenation during flight. It has been demonstrated that the PaO2 and SpO2 of
Asthma
Asthma is the most common respiratory disorder among commercial air travelers.1 In general, patients with stable asthma that is well controlled with medication can fly safely. It is recommended that physicians counsel asthma patients on the necessity of continuing all medication as prescribed during air travel and the importance of carrying enough medication with them to last for the duration of the trip. It is also recommended that they carry a short-acting inhaled bronchodilator and a course
Restrictive and Interstitial Lung Disease
Two studies have shown that patients with restrictive and interstitial lung diseases may be at high risk of developing a resting PaO2 below the recommended lower limit of 50 mm Hg at a simulated cabin altitude of 8,000 feet. These studies also showed that mild exercise at 8,000 feet may cause a further decline in PaO2 to a very low level.47., 62. Thus, all patients with restrictive or interstitial lung disease should be advised to refrain from exercise during air travel. Diffusion abnormalities,
Pulmonary Hypertension
Patients with pulmonary hypertension, either primary or secondary, are at high risk for complications during commercial air travel. Given the considerable individual variability in hypoxia-induced pulmonary vasoconstriction, even a mild increase in hypoxia during flight may cause very high pulmonary artery pressure and pulmonary vascular resistance in some patients. These changes could potentially cause a life-threatening decrease in cardiac output and right heart failure during flight.16., 39.
Pneumothorax
Boyle’s Law states that the volume of gas in a closed space is inversely proportional to the pressure of the gas. Therefore, as the barometric pressure of air in an aircraft cabin falls with ascent to cruising altitude, the volume of air in body cavities will expand. In noncommunicating body cavities, such as a closed pneumothorax, there is no way for the expanding gas to escape and equilibrate with the external environment. Thus, the volume of air in a closed pneumothorax will continue to
Airline-Provided Oxygen
The logistics of providing supplemental oxygen during air travel can be challenging for both the patient and physician. Patients are not permitted to carry their own compressed gas oxygen cylinders aboard commercial aircraft. However, most airlines will provide supplemental oxygen to passengers with an oxygen prescription from their physician. Each airline has its own policy for providing supplemental oxygen and there is usually a fee charged for this service. The number of oxygen cylinders
Portable Oxygen Concentrators
In 2005, the United States Federal Aviation Administration (FAA) issued a new rule which made it easier for individuals who require supplemental oxygen to fly on commercial aircraft.69 This rule allows, but does not require, airlines to permit individuals to carry FAA-approved portable oxygen concentrators with them aboard commercial aircraft and to use them during flight. At the present time there are 5 portable oxygen concentrator devices that have been approved by the FAA for use during
References (70)
- et al.
Assessment of ventilatory response to hypoxia: methods and interpretation
Chest
(1976) Air travel and oxygen therapy in cardiopulmonary patients
Chest
(1992)Medical aspects of commercial air travel
Am J Emerg Med
(1989)- et al.
Preflight medical screening of patients: analysis of health and flight characteristics
Chest
(1993) - et al.
The preflight evaluation: a comparison of the hypoxia inhalation test with hypobaric exposure
Chest
(1995) - et al.
Reference values for the 6-min walk test in healthy subjects 20–50 years old
Respir Med
(2006) - et al.
Oxygen supplementation during air travel in patients with chronic obstructive lung disease
Chest
(1992) - et al.
Pulmonary hypertensive diseases
Chest
(1984) - et al.
Medical guidelines for air travel, 2nd Edition
Aviat Space Environ Med
(2003) Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations
Thorax
(2002)
Altitude-related hypoxia: risk assessment and management for passengers on commercial aircraft
Aviat Space Environ Med
Responding to medical events during commercial airline flights
N Engl J Med
Airlines industry profile: global.
In-flight medical emergencies: an overview
BMJ
In-flight medical events and aircraft diversions: one airline’s experience
Aviat Space Environ Med
Frequency and types of medical emergencies among commercial air travelers
JAMA
Obstructive lung disease and altitude adaptation
JAMA
Hypoxemia during air travel in patients with chronic obstructive pulmonary disease
Ann Intern Med
Hypoxia-altitude simulation test: evaluation of patients with chronic airway obstruction
Am Rev Respir Dis
Air travel in patients with chronic obstructive pulmonary disease
Ann Intern Med
Advising COPD patients about commercial air travel
J Resp Dis
Kardiopulmonale belastung von flugpassagieren mit obstruktiven ventilationssstorungen
Schweiz Med Wschr
Hypoxia and Air Travel
Air travel hypoxemia with chronic obstructive pulmonary disease
Ann Intern Med
Effects of moderate altitude on patients with pulmonary and cardiac impairment
Calif Med
Air travel and respiratory disease
BMJ
Health issues of air travel
Annu Rev Public Health
Fitness to travel by air, I: physiological considerations
Br Med J
Fitness to travel by air, II: specific medical considerations
Br Med J
Effect of exposure to 15% oxygen on breathing patterns and oxygen saturation in infants: interventional study
BMJ
Predicting hypoxaemia during flights in children with cystic fibrosis
Thorax
Commercial airline travel decreases oxygen saturation in children
Pediatr Emerg Care
The effects of flight and altitude
Arch Dis Child
Preflight hypoxic challenge in infants and young children with respiratory disease
Thorax
Cited by (43)
Home management
2023, Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular DiseaseCommercial Air Travel for Passengers With Cardiovascular Disease: Stressors of Flight and Aeromedical Impact
2021, Current Problems in CardiologyPostobstructive pulmonary edema in the setting of aspiration and air travel
2014, Journal of Emergency MedicineCommercial air travel after pneumothorax: A review of the literature
2013, Air Medical JournalCitation Excerpt :Several prior reviews have attempted to provide guidelines for safe waiting periods before flying after a patient has suffered a pneumothorax. Many of these reviews take a conservative approach to flight with a pneumothorax, with most describing a pneumothorax as an absolute contraindication to flight.17–20 Recommendations for the waiting period between pneumothorax resolution and flight range from 7 days21 to 2 weeks,18,19 3 weeks,20 and 6 weeks.17
Pulmonary arterial hypertension
2011, Critical Care Nursing Clinics of North AmericaCitation Excerpt :Oxygen supplementation to maintain oxygen saturation greater than 90% is recommended.5 Patients with a preflight oxygen saturation of less than 92% should receive oxygen during their flight.35 Patients may need resources on how to find out airline's policy on oxygen in flight.